UAMS First in Nation to Offer Groundbreaking Therapy for Treatment-Resistant Depression
June 12, 2024
June 12, 2024
LITTLE ROCK, Arkansas, June 12 -- The University of Arkansas for Medical Sciences issued the following news release:
The University of Arkansas for Medical Sciences (UAMS) is the first medical facility in the United States to provide an innovative therapeutic treatment for major depressive disorder (MDD).
The SAINT(R) neuromodulation system, developed by Magnus Medical, Inc., has been approved by the U.S. Food and Drug Administration to treat adults with depression who . . .
The University of Arkansas for Medical Sciences (UAMS) is the first medical facility in the United States to provide an innovative therapeutic treatment for major depressive disorder (MDD).
The SAINT(R) neuromodulation system, developed by Magnus Medical, Inc., has been approved by the U.S. Food and Drug Administration to treat adults with depression who . . .